Kv1. 3 expression on CD4 ( ) T cells promotes interleukin-17A-associated airway inflammation and airway remodeling in asthma
1. 系统已在2025-04-23 17:36:35对应助文件进行删除
2. 如有需要请重新发布求助信息
注: 所有应助的资源仅供学习交流使用, 不得违反相关法律法规
DOI:
文献链接:
其他信息:
B Sun, J Lin
Translational Research, 2025
Elsevier
Background Different types of T helper cells play an important role in disease severity and treatment response in patients with asthma. The potassium channel Kv1. 3 is a type of potentially therapeutic target in T-cell-mediated inflammatory diseases. Objective This study aimed to explore the potential of Kv1. 3 as a therapeutic target for asthma and to assess the efficacy of the Kv1. 3 inhibitor PAP-1 in the treatment of asthma. Methods Kv1. 3 expression on CD4 T cells was determined using data from public databases. CD4 T cells were …
